Efficacy of bevacizumab with cisplatin and gemcitabine in Asian patients with advanced or recurrent non-squamous non-small cell lung cancer who have not received prior chemotherapy: A substudy of the Avastin in Lung trial

• المؤلفون الرئيسيون: Tony S K Mok, Te Chun Hsia, Chun Ming Tsai, Kenneth Tsang, Gee Chen Chang, John Wen Cheng Chang, Sirisinha Thitiya, Virote Sriuranpong, Sumitra Thongprasert, Daniel Tt Chua, Nicola Moore, Christian Manegold
• التنسيق: دورية
• منشور في: 2018
• الموضوعات: Medicine
• الوصول للمادة أونلاين: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79956133688&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/50229

Aim: The phase III AVAiL study evaluated the efficacy and safety of the anti-vascular epidermal growth factor agent bevacizumab combined with platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer (NSCLC). We report the results of a preplanned analys...